eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.
作者信息
Stoneley M, Willis A E
机构信息
MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
出版信息
Cell Death Differ. 2015 Apr;22(4):524-5. doi: 10.1038/cdd.2014.210. Epub 2015 Jan 23.
Abstract
摘要
相似文献
1
eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.真核生物翻译起始因子4A1（eIF4A1）是雌激素受体阴性乳腺癌中一个很有前景的新治疗靶点。
Cell Death Differ. 2015 Apr;22(4):524-5. doi: 10.1038/cdd.2014.210. Epub 2015 Jan 23.
2
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.乳腺癌中的恶性表型是由 eIF4A1 介导的翻译景观变化驱动的。
Cell Death Dis. 2015 Jan 22;6(1):e1603. doi: 10.1038/cddis.2014.542.
3
Plakophilin 1 stimulates translation by promoting eIF4A1 activity.桥粒斑蛋白 1 通过促进 eIF4A1 活性来刺激翻译。
J Cell Biol. 2010 Feb 22;188(4):463-71. doi: 10.1083/jcb.200908135. Epub 2010 Feb 15.
4
Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer.术前近距离放疗后 EIF4A1 表达降低可预测宫颈癌患者的肿瘤特异性生存更好。
Int J Gynecol Cancer. 2014 Jun;24(5):908-15. doi: 10.1097/IGC.0000000000000152.
5
eIF4A1 enhances LARP1-mediated translational repression during mTORC1 inhibition.eIF4A1 增强 mTORC1 抑制时 LARP1 介导的翻译抑制。
Nat Struct Mol Biol. 2024 Oct;31(10):1557-1566. doi: 10.1038/s41594-024-01321-7. Epub 2024 May 21.
6
mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3-mediated ubiquitination of eIF4A1 in cancer cells.mTORC1/S6K1 信号通路通过调节 CRL3 介导的 eIF4A1 泛素化促进癌细胞中持续的致癌翻译。
Elife. 2024 May 13;12:RP92236. doi: 10.7554/eLife.92236.
7
Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication.人巨细胞病毒 miR-US25-2-3p 的过表达下调 eIF4A1 并抑制 HCMV 复制。
FEBS Lett. 2013 Jul 11;587(14):2266-71. doi: 10.1016/j.febslet.2013.05.057. Epub 2013 Jun 6.
8
Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity.基于靶标的筛选发现海洋天然产物艾拉醇是一种新型的翻译起始抑制剂，具有抗肿瘤活性。
Clin Cancer Res. 2018 Sep 1;24(17):4256-4270. doi: 10.1158/1078-0432.CCR-17-3645. Epub 2018 May 29.
9
High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.肿瘤内高水平的 eIF4A1 表达促进上皮-间充质转化，并预测胃癌的不良预后。
Acta Biochim Biophys Sin (Shanghai). 2020 Mar 18;52(3):310-319. doi: 10.1093/abbs/gmz168.
10
Critical and differential roles of eIF4A1 and eIF4A2 in B-cell development and function.真核生物翻译起始因子4A1（eIF4A1）和真核生物翻译起始因子4A2（eIF4A2）在B细胞发育和功能中的关键及差异作用。
Cell Mol Immunol. 2025 Jan;22(1):40-53. doi: 10.1038/s41423-024-01234-x. Epub 2024 Nov 8.
引用本文的文献
1
Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers.真核生物翻译起始因子4A1在癌症发病机制及治疗中的作用
Front Mol Biosci. 2023 Nov 9;10:1289650. doi: 10.3389/fmolb.2023.1289650. eCollection 2023.
2
Regulation of mRNA translation by estrogen receptor in breast cancer.雌激素受体在乳腺癌中对 mRNA 翻译的调控。
Steroids. 2023 Dec;200:109316. doi: 10.1016/j.steroids.2023.109316. Epub 2023 Oct 6.
3
Identification and Analysis of Hub Genes and Immune Cells Associated with the Formation of Acute Aortic Dissection.鉴定和分析与急性主动脉夹层形成相关的枢纽基因和免疫细胞。
Comput Math Methods Med. 2023 Feb 8;2023:8072369. doi: 10.1155/2023/8072369. eCollection 2023.
4
Potential diagnostic role of circulating MiRNAs in colorectal cancer.循环 miRNAs 在结直肠癌中的潜在诊断作用。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320221144565. doi: 10.1177/03946320221144565.
5
Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.具有抗肿瘤活性的新型 eIF4A1 抑制剂在淋巴瘤中的应用。
Mol Med. 2022 Sep 4;28(1):101. doi: 10.1186/s10020-022-00534-0.
6
Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers.真核生物起始因子4A家族蛋白在人类癌症中的表达及功能作用
Front Cell Dev Biol. 2021 Nov 19;9:711965. doi: 10.3389/fcell.2021.711965. eCollection 2021.
7
USP15 Enhances Re-epithelialization Through Deubiquitinating EIF4A1 During Cutaneous Wound Repair.USP15在皮肤伤口修复过程中通过去泛素化EIF4A1促进再上皮化。
Front Cell Dev Biol. 2020 Jun 26;8:529. doi: 10.3389/fcell.2020.00529. eCollection 2020.
8
Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.PDCD4/eIF4A1信号异常表达可预测早期口腔鳞状细胞癌术后复发
Cancer Manag Res. 2019 Nov 11;11:9553-9562. doi: 10.2147/CMAR.S223273. eCollection 2019.
9
Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.翻译杂技：癌细胞如何利用翻译起始的替代模式。
EMBO Rep. 2018 Oct;19(10). doi: 10.15252/embr.201845947. Epub 2018 Sep 17.
10
eIF4A RNA Helicase Associates with Cyclin-Dependent Protein Kinase A in Proliferating Cells and Is Modulated by Phosphorylation.真核起始因子4A（eIF4A）RNA解旋酶在增殖细胞中与细胞周期蛋白依赖性蛋白激酶A相关，并受磷酸化调节。
Plant Physiol. 2016 Sep;172(1):128-40. doi: 10.1104/pp.16.00435. Epub 2016 Jul 7.
本文引用的文献
1
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.乳腺癌中的恶性表型是由 eIF4A1 介导的翻译景观变化驱动的。
Cell Death Dis. 2015 Jan 22;6(1):e1603. doi: 10.1038/cddis.2014.542.
2
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.eIF4F 是一种对 BRAF 和 MEK 抑制剂抗癌疗法产生抵抗的连接点。
Nature. 2014 Sep 4;513(7516):105-9. doi: 10.1038/nature13572. Epub 2014 Jul 27.
3
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.RNA G-四链体导致癌症中 eIF4A 依赖性癌基因翻译。
Nature. 2014 Sep 4;513(7516):65-70. doi: 10.1038/nature13485. Epub 2014 Jul 27.
4
A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.真核起始因子 4B 过表达在弥漫性大 B 细胞淋巴瘤发病机制中的作用。
Leukemia. 2014 May;28(5):1092-102. doi: 10.1038/leu.2013.295. Epub 2013 Oct 18.
5
Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity.人类 eIF4E 通过刺激 eIF4A 解旋酶活性促进 mRNA 重排。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13339-44. doi: 10.1073/pnas.1303781110. Epub 2013 Jul 30.
6
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.通过靶向抑制真核起始因子 4A 来改变化疗反应。
Blood Cancer J. 2013 Jul 19;3(7):e128. doi: 10.1038/bcj.2013.25.
7
The biological and therapeutic relevance of mRNA translation in cancer.mRNA 翻译在癌症中的生物学和治疗相关性。
Nat Rev Clin Oncol. 2011 May;8(5):280-91. doi: 10.1038/nrclinonc.2011.16. Epub 2011 Mar 1.
8
Dysregulation of protein synthesis and disease.蛋白质合成失调与疾病。
J Pathol. 2010 Jan;220(2):140-51. doi: 10.1002/path.2627.
9
Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.环戊并[b]苯并呋喃类化合物西维因的抗肿瘤活性及作用机制
PLoS One. 2009;4(4):e5223. doi: 10.1371/journal.pone.0005223. Epub 2009 Apr 29.
10
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.肿瘤抑制因子Pdcd4：功能与调控机制解析的最新进展
Biol Cell. 2009 Jun;101(6):309-17. doi: 10.1042/BC20080191.
Zotero 插件